Biopharmaceutical Study of an Injectable Dosage Form of the New Antiaggregant Substance 3-Methyl-8-(Piperazin-1-yl)-7-(Thietan-3-yl)-1-Ethyl-1H-Purine-2,6(3H,7H)-Dione Hydrochloride
Crossref DOI link: https://doi.org/10.1007/s11094-021-02364-6
Published Online: 2021-04-10
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smirnova, L. A.
Spasov, A. A.
Khaliullin, F. A.
Kucheryavenko, A. F.
Ryabukha, A. F.
Abramov, O. K.
Text and Data Mining valid from 2021-04-01
Version of Record valid from 2021-04-01
Article History
Received: 16 November 2020
First Online: 10 April 2021